Iimvavanyo ze-US kunye neYurophu Iziphumo zeGlucosamine
Kwi-College yase-American College yeRheumatology Annual Scientific Meeting (2005), iziphumo zoluvavanyo lwe-glucosamine ezimbini zenziwe. Iziphumo zezilingo ezimbini zazikulindeleke kakhulu ngabaphandi, oogqirha, kunye nezigulane ezazifuna ukuqinisekiswa ukuba i-glucosamine yindlela efanelekileyo yokunyangwa kwe-arthritis .
- I-GAIT (iGlucosamine / Chondroitin I-Arthritis Intervention Trial) yaxhaswa ngemali yiZiko leSizwe lezeMpilo kwaye lenzelwe ukufumana ukhuseleko kunye nokusebenza kakuhle kunye ne-glucosamine kunye ne- chondroitin , ithathwe ngokwahlukileyo okanye kunye.
- ISIKHOKELO (iGlucosamine Unum In Die Efficiency) yilingo leYurophu.
I-GAIT (iGlucosamine / Chondroitin I-Arthritis Ingenelelo lokungenelela kwe-Arthritis) Isigaba I
Kwi-GAIT (iGlucosamine / Chondroitin I-Arthritis Intervention Trial), izigulane ezingama-1,600 ezine- knee osteoarthritis ezibuhlungu zifunyenwe kumaziko e-US e-Rheumatology. Abathathi-nxaxheba bafundela ubuhlungu obudlulileyo bamadolo kwaye babenobungqina be- x-ray ye-knee osteoarthritis. Ngethuba lokufunda i-GAIT, izigulane:
- Kwavavanywa ekuqaleni kweso sifundo.
- Bavavanywa kwiiveki 4, 8, 16, 24.
- Izigulane zazingenangqondo ukufumana i-glucosamine HCl, i-sodium chondroitin sulfate, zombini izongezo, i- celecoxib (igama lophawu lweCelebrex) , okanye i-placebo.
- Izigulane zavunyelwa ukufikelela kwi-4 000 mg ngosuku lwe-acetaminophen.
Iziphumo ezivela kwi-GAIT (Glucosamine / Chondroitin Arthritis Intervention Trial)
- Iziphumo zityhila ukuba ukuhlanganiswa kwe-glucosamine kunye ne-chondroitin kungcono kunendawo ye-placebo kodwa iinzuzo zibonakala zixhomekeke kubukhulu beentlungu.
- Kwizigulane ezineentlungu ezidlulileyo ze-osteoarthritis, i-79.2% ithatha i-glucosamine / i-chondroitin inxungulo yeentlungu.
- Kwizigulane ezithatha i-celecoxib, i-69.4% ivuselelwe intlungu. Kwizigulane ezithatha i-glucosamine yedwa, i-65.7% yafumana uxolo, njengoko kwenza i-61.4% yezigulane zithatha i-chondroitin yodwa. Kwakhona, i-54.3% ithatha indawo yendawo ibika uxolo.
- Kwizigulane ezinobunzima be-knee osteoarthritis, inxalenye ye-glucosamine / chondroitin yayingasebenzi kakhulu kunokuba i-placebo.
ISIKHOKELO (Glucosamine Unum In Die Efficiency)
Kwakukho izigulane ezingama-318 kwi-GUIDE ukufunda kunye ne-knee osteoarthritis (abafazi abangama-88%). Izigulane zazingenakulinganiswa ukuba zithathe i-oral glucosamine sulphate powder (1500 mg ngosuku), i- acetaminophen (1000 mg kathathu ngosuku), okanye indawo ye-placebo ngaphezu kweenyanga ezili-6. Wonke amaqela avunyelwe ukuthatha ibuprofen njengoko kuyimfuneko.
Iziphumo ezivela kwisikhokelo (Glucosamine Unum In Die Efficiency)
- Bobabini i-glucosamine sulfate kunye ne-acetaminophen babesebenze ngakumbi ekunciphiseni ubuhlungu kunendawo ye-placebo.
- Izigulana ezithatha i-glucosamine sulfate zibonise ukukhululeka ngakumbi kunezigulane kwi-acetaminophen.
- Kwakugqitywa ukuba i-1500 mg yemihla yomlomo ye-glucosamine sulfate ingaba yonyango olukhethiweyo lwe-knee osteoarthritis.
Isigaba II nesigaba III I-GAIT Iziphumo
Iziphumo ezivela kwisigaba sesibini se-GAIT zipapashwe kwiphepha leArthritis & Rheumatism ngo-2008. Isigaba II sihlolisise ukuhlanganiswa kwe-glucosamine kunye ne-chondroitin ukukhusela umonakalo ohlanganyelwe wamadolo. Ukuhlanganiswa kwe-glucosamine kunye ne-chondroitin kwakubonakala kungabonakaliyo ekukhuseleni umonakalo odibeneyo ohlobene ne-osteoarthritis kune-placebo.
Abathathi-nxaxheba abafundayo abalahlekelwa ubuncinane bendawo yokudibanisa ngaphezu kweminyaka emibini bephakathi kwamaqela athatha i-glucosamine okanye i-chondroitin yodwa. Mhlawumbi, ukuthatha iipilisi zombini kunye neempembelelo ezichaphazelayo, ezinokuthi zichaze ukusebenza okuncinci kwezibonelelo xa zisetyenziselwa ukudibanisa.
Isigaba III, esasibonile iminyaka emine yedatha, sityhile ukuba izibonelelo ezidibeneyo okanye zodwa zazingenaso inzuzo enkulu kuncedo lwexolo kunokuba i-celecoxib okanye indawo ye-placebo. Iziphumo zapapashwa ngo-2010 kwiphepha le- Annals of Rheumatic Disease .
Incomo yeGlucosamine
- Ngaphambi kokuzama i-glucosamine / chondroitin ukuxoxisana nodokotela wakho kwaye ubuze indlela eya kuhambelana ngayo neprogram yakho yonyango yangoku.
- Hlalani kumachiza enu awamiselweyo. Izibonelelo azishiyi indawo yemithi enqunyiwe.
- Funda malunga ne-glucosamine ngokwenza uphando lwakho. Fumana imithombo yolwazi enokuthenjwa.
- Landela izikhokelo ezichazwe ngumenzi wesongezelelo okanye ubuze ugqirha wakho malunga nesilinganiso esifanelekileyo.
- Gwema ukudibanisa nezinye izongezo ezahlukeneyo.
- Thenga kumvelisi ohloniphekileyo. Yazi oko ufumanayo.
Ngaphantsi
Ngo-2012, i-American College yeRheumatology yashicilela iingcebiso zonyango kwi-osteoarthritis. Kwisikhokelo, i-chondroitin okanye i-glucosamine ayizange ikhuthazwe kunyango lokuqala lwe-osteoarthritis. I-Chondroitin kunye ne-glucosamine izongezo zodwa okanye ngokudibeneyo akunakho ukusetyenziswa ngonyango kuzo zonke izigulane. Ingasebenza kwiigulane ezithile, kwaye ukuba kusebenza kuwe, qhubeke unyango - lubonwa njengekhuselekile.
Imithombo:
Impembelelo ye-glucosamine kunye / okanye i-chondroitin sulfate ekuqhubeni kwe-knee osteoarthritis: ingxelo evela kwi-glucosamine / chondroitin ye-arthritis. Sawitzke et al. Arthritis & Rheumatism. 2008 Oct; 58 (10): 3183-91.
http://www.ncbi.nlm.nih.gov/pubmed/18821708
I-Glucosamine / Chondroitin I-Arthritis Yokungenelela Kwemvavanyo (GAIT). NIH. Ushintshe ngoJanuwari 2012.
https://nccih.nih.gov/research/results/gait
Ukusebenza kliniki kunye nokukhuselwa kwe-glucosamine, i-chondroitin sulphate, ukudibanisa kwabo, i-celecoxib okanye i-placebo ethathwe ukunyanga i-osteoarthritis yamadolo: iziphumo zeminyaka emi-2 ukusuka kwi-GAIT. NgoJuni 2010. Iziganeko zezifo zeRheumatic. 2010; 69: 1459-1464
http://ard.bmj.com/content/69/8/1459.abstract?sid=fc95aeb7-1d79-4a79-9dac-c65916ca2125
Iziphakamiso zokusetyenziswa kwe-Nonpharmacologic kunye ne-Pharmacologic Therapies kwi-Osteoarthritis ye-Hand, Hip, kunye ne-Knee.I-College of Rheumatology 2012. (Ukunakekelwa kweArthritis & Uphando I-Vol. 64, No. 4, Epreli 2012, iphe. 465-474.)